Nevro to Participate in Wells Fargo 2022 MedTech R&D Spotlight Call Series

REDWOOD CITY, Calif., Feb. 18, 2022 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro’s Chairman, CEO and President, Rod…

About the Author

has written 20655 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com